-
Recent Patent Ruling A Positive For Pfizer
Thursday, August 18, 2016 - 2:26pm | 331Read More...A Federal District Court in Massachusetts recently issued a patent ruling that is "favorable" for Pfizer Inc. (NYSE: PFE), according to Gregg Gilbert of Deutsche Bank. As noted by Gilbert, the District Court ruled in favor of Pfizer and Celltrion and said that Johnson & Johnson (NYSE: JNJ)'s...
-
Pfizer Receives FDA Approval For Cheaper Version Of Johnson & Johnson's Top Drug Remicade
Wednesday, April 6, 2016 - 10:45am | 327Read More...Pfizer Inc. (NYSE: PFE) announced after Tuesday's market close that the U.S. Food and Drug Administration approved INFLECTRA, the first and only biosimilar monoclonal antibody therapy, and only the second biosimilar to be approved in the US. INFLECTRA is a treatment indicated for reducing...
